Publications
45 results found
Scourfield A, Tan LKK, Nelson M, 2010, Severe septic-shock like reaction to co-trimoxazole in an HIV-positive man, INTERNATIONAL JOURNAL OF STD & AIDS, Vol: 21, Pages: 521-523, ISSN: 0956-4624
- Author Web Link
- Cite
- Citations: 6
LKK T, Carlone GM, Borrow R, 2010, CURRENT CONCEPTS Advances in the Development of Vaccines against Neisseria meningitidis, NEW ENGL J MED, Vol: 362, Pages: 1511-1520, ISSN: 0028-4793
Tan LKK, Carlone GM, Borrow R, 2010, Advances in the development of vaccines against Neisseria meningitidis., N Engl J Med, Vol: 362, Pages: 1511-1520
Tan L, Schneider M, Caesar J, et al., 2009, THE INTERACTION BETWEEN FACTOR H AND NEISSERIA MENINGITIDIS, Publisher: W B SAUNDERS CO LTD, Pages: S438-S438, ISSN: 0163-4453
Tan LKK, Gilleece Y, Mandalia S, et al., 2009, Reduced glomerular filtration rate but sustained virologic response in HIV/hepatitis B co-infected individuals on long-term tenofovir, JOURNAL OF VIRAL HEPATITIS, Vol: 16, Pages: 471-478, ISSN: 1352-0504
- Author Web Link
- Cite
- Citations: 14
Stebbing J, Wong N, Tan L, et al., 2009, The Relationship Between Prolonged Antiretroviral Therapy and Cryptogenic Liver Disease, JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, Vol: 50, Pages: 554-556, ISSN: 1525-4135
- Author Web Link
- Cite
- Citations: 3
Tan LKK, Yacoub S, Scott S, et al., 2008, Acute lung injury and other serious complications of Plasmodium vivax malaria, LANCET INFECT DIS, Vol: 8, Pages: 449-454, ISSN: 1473-3099
Plasmodium vivax infection is classified among the so-called benign malarias, but it is increasingyly recognised that serious and even life-threatening complications may occur. We present the case of a returning traveller with P vivax infection who developed acute lung injury 3 days into treatment, and discuss the serious complications of this infection. The case highlights the fact that P vivax infection is benign by name but not always by nature.
Wong THN, Tan L, Wing C, et al., 2008, Cryptogenic liver disease in HIV infected patients treated with anti-retroviral drugs, British Infection Society 10th Annual Meeting, Pages: 307-307, ISSN: 0163-4453
Tan LK, Nelson M, 2008, Maraviroc: a CCR5 antagonist, Future HIV therapy, Vol: 2, Pages: 111-123
HIV requires binding to both the CD4 molecule and a coreceptor to enable entry into the cell. CCR5 is a chemokine receptor that is utilized as a coreceptor by the majority of virus in early asymptomatic HIV infection. Maraviroc is a novel small molecule CCR5 antagonist which, in Phase IIb/III clinical trials up to 48 weeks, has been shown to be efficacious as part of an optimized antiretroviral regimen against CCR5 tropic HIV-1 in treatment-experienced patients. A further trial has demonstrated its noninferiority to efavirenz in achieving a HIV viral load less than 400 copies/ml as part of highly active antiretroviral therapy in treatment-naive individuals. It has recently received regulatory approval for use in North America and Europe in treatment-experienced patients. With increasing use, the role of maraviroc in the treatment of HIV-infected patients will be more clearly defined.
Tan LKK, Lacey S, Mandalia S, et al., 2008, Hospital-based study of viridans streptococcal bacteraemia in children and adults, JOURNAL OF INFECTION, Vol: 56, Pages: 103-107, ISSN: 0163-4453
- Author Web Link
- Cite
- Citations: 5
Tan LK, Yacoub S, Scott S, et al., 2008, Acute lung injury and other serious complications of Plasmodium vivax malaria., Lancet Infectious Diseases, Vol: 8, Pages: 449-454
Tan LKK, Powrie DJ, Rowland R, et al., 2007, Fever and haemoptysis in an injecting drug user, EUROPEAN RESPIRATORY JOURNAL, Vol: 29, Pages: 1061-1063, ISSN: 0903-1936
- Author Web Link
- Cite
- Citations: 6
Tan L, Lacey S, Melzer M, 2007, The clinical significance of Viridans streptococcal bacteraemia in patients at a district general hospital, 17th European Congress of Clinical Microbiology and Infectious Diseases/25th International Congress of Chemotherapy, Publisher: ELSEVIER SCIENCE BV, Pages: S630-S630, ISSN: 0924-8579
Tan LKK, 2006, Good news for treating HIV and tuberculosis co-infection?, Thorax, Vol: 61, Pages: 816-816, ISSN: 0040-6376
Tan L, 2005, Teaching medicine in a developing country, BMJ, Vol: 331, Pages: s130-s131, ISSN: 0959-8138
This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.